35 filings
8-K
CMPX
Compass Therapeutics Inc
25 Apr 24
Regulation FD Disclosure
8:00am
8-K
CMPX
Compass Therapeutics Inc
21 Mar 24
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
9:00am
8-K
CMPX
Compass Therapeutics Inc
9 Jan 24
Departure of Directors or Certain Officers
5:30pm
8-K
CMPX
Compass Therapeutics Inc
5 Jan 24
Compass Therapeutics Provides Corporate Update
8:00am
8-K
CMPX
Compass Therapeutics Inc
9 Nov 23
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
7:30am
8-K
kn7k1hirp xy1
3 Aug 23
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
8:00am
8-K
bwmrwp un
15 Jun 23
Submission of Matters to a Vote of Security Holders
11:15am
8-K
l0g3whcfxgge3so8
4 May 23
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
8:30am
8-K
b34gv rg4b5a5kzfpr
24 Apr 23
Departure of Directors or Certain Officers
4:30pm
8-K
u0i5 dcey14e7mlyqi0
10 Mar 23
Regulation FD Disclosure
11:56am
8-K
dewmu 18oltkpyuhy
24 Feb 23
Departure of Directors or Certain Officers
4:01pm
8-K
iolf343 z64cxyp08ax
10 Feb 23
Departure of Directors or Certain Officers
4:00pm
8-K
rwaltb7vx
19 Jan 23
Other Events
5:00pm
8-K
hq50g169
29 Nov 22
Departure of Directors or Certain Officers
4:06pm
8-K
eyy65k63l2
2 Nov 22
Compass Therapeutics Announces $80 Million Private Placement
5:00pm
8-K
5ag684kn uxbip4c0zhe
19 Aug 22
Departure of Directors or Certain Officers
4:00pm
8-K
vcti idev
1 Aug 22
Entry into a Material Definitive Agreement
8:20am
8-K
ve7f28 0nf
31 May 22
Submission of Matters to a Vote of Security Holders
1:41pm
8-K
fssmrl o9zbsxg
4 May 22
Compass Therapeutics Reports Positive Interim Phase 2 Data of CTX-009 in Combination with Paclitaxel in Biliary Tract Cancers
7:00am
8-K
p2k5llogfg6omzv1ku4o
26 Apr 22
Compass Therapeutics Announces Appointment of Two New Directors to its Board
8:01am